These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 21135378)

  • 21. Early cognitive impairment in multiple sclerosis detected by a screening with a vocabulary-test.
    Rösche J; Mauch E; Kornhuber HH
    Acta Neurol (Napoli); 1994 Dec; 16(5-6):249-54. PubMed ID: 7709795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological investigations of multiple sclerosis: a clinical perspective.
    O'Connor MG
    Clin Neurosci; 1994; 2(3-4):225-8. PubMed ID: 7749892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive assessment in MS.
    Langdon D
    Neurodegener Dis Manag; 2015; 5(6 Suppl):43-5. PubMed ID: 26611272
    [No Abstract]   [Full Text] [Related]  

  • 24. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response variability is associated with self-reported cognitive fatigue in multiple sclerosis.
    Bruce JM; Bruce AS; Arnett PA
    Neuropsychology; 2010 Jan; 24(1):77-83. PubMed ID: 20063948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of recruitment and participation bias in neuropsychological research among MS patients.
    Duquin JA; Parmenter BA; Benedict RH
    J Int Neuropsychol Soc; 2008 May; 14(3):494-8. PubMed ID: 18419848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric multiple sclerosis.
    Chitnis T; Krupp L; Yeh A; Rubin J; Kuntz N; Strober JB; Chabas D; Weinstock-Guttmann B; Ness J; Rodriguez M; Waubant E
    Neurol Clin; 2011 May; 29(2):481-505. PubMed ID: 21439455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paced visual serial addition test in multiple sclerosis.
    Nagels G; Geentjens L; Kos D; Vleugels L; D'hooghe MB; Van Asch P; Vuylsteke K; De Deyn PP
    Clin Neurol Neurosurg; 2005 Apr; 107(3):218-22. PubMed ID: 15823678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
    Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropsychological assessment in multiple sclerosis].
    Barroso J; Nieto A; Olivares T; Wollmann T; Hernández MA
    Rev Neurol; 2000 May 16-31; 30(10):985-8. PubMed ID: 10919201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive screening in multiple sclerosis.
    Scherer P
    J Neurol; 2007 May; 254 Suppl 2():II26-9. PubMed ID: 17503125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study.
    Olazarán J; Cruz I; Benito-León J; Morales JM; Duque P; Rivera-Navarro J
    Eur Neurol; 2009; 61(2):87-93. PubMed ID: 19039226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Home-based personalized cognitive training in MS patients: a study of adherence and cognitive performance.
    Shatil E; Metzer A; Horvitz O; Miller A
    NeuroRehabilitation; 2010; 26(2):143-53. PubMed ID: 20203380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
    Christodoulou C; Melville P; Scherl WF; Morgan T; MacAllister WS; Canfora DM; Berry SA; Krupp LB
    J Int Neuropsychol Soc; 2005 Sep; 11(5):614-9. PubMed ID: 16212689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process evaluation of a self-management cognitive program for persons with multiple sclerosis.
    Shevil E; Finlayson M
    Patient Educ Couns; 2009 Jul; 76(1):77-83. PubMed ID: 19118971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive and brain imaging measures of multiple sclerosis.
    Pozzilli C; Passafiume D; Anzini A; Borsellino G; Koudriavsteva T; Sarlo G; Fieschi C
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):133-6. PubMed ID: 1345734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cognitive functions in multiple sclerosis].
    Vicens A; Iriarte J; de Castro P; Castejón C; Martínez-Lage JM
    Neurologia; 1992; 7(7):171-5. PubMed ID: 1419085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment and rehabilitation of cognitive impairment in multiple sclerosis.
    Messinis L; Kosmidis MH; Lyros E; Papathanasopoulos P
    Int Rev Psychiatry; 2010; 22(1):22-34. PubMed ID: 20233112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.